AIDX

20/20 Biolabs, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$0.2

Price (1 Year)

$14.78 $0.2

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %5.6 / %30
Non-compliant assets / Total market cap %0 / %30
Non-compliant revenue / Total income %1.9 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers.

Website

Analysis (Turkish): AIDX Hissesi Caiz mi, Helal mi? 20/20 Biolabs, Inc. Katılım Analizi